Bioceres Crop Solutions Corp. Share Price

Equities

BIOX

KYG1117K1141

Agricultural Chemicals

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
12.05 USD -0.25% Intraday chart for Bioceres Crop Solutions Corp. -0.58% -12.24%
Sales 2024 * 492M 39.42B Sales 2025 * 598M 47.9B Capitalization 757M 60.61B
Net income 2024 * 26M 2.08B Net income 2025 * 75M 6B EV / Sales 2024 * 1.54 x
Net cash position 2024 * - 0 Net Debt 2025 * 196.8 15.75K EV / Sales 2025 * 1.27 x
P/E ratio 2024 *
29.6 x
P/E ratio 2025 *
10.5 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 55.26%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Bioceres Crop Solutions Corp., Q2 2024 Earnings Call, Feb 08, 2024
Bioceres Crop Solutions Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2023 CI
Transcript : Bioceres Crop Solutions Corp., Q1 2024 Earnings Call, Nov 14, 2023
Bioceres Crop Solutions Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Transcript : Bioceres Crop Solutions Corp. - Shareholder/Analyst Call
Moolec Science Signs Agreements to Issue Convertible Notes to Grupo Insud, Bioceres Crop Solutions MT
Bioceres Crop Solutions Slumped in Late-Hours Activity Monday After Swinging to Fiscal Q4 GAAP Loss as Revenue Stagnates MT
Transcript : Bioceres Crop Solutions Corp., Q4 2023 Earnings Call, Sep 11, 2023
Earnings Flash (BIOX) BIOCERES CROP SOLUTIONS Posts Q4 Revenue $104.7M, vs. Street Est of $102.4M MT
Bioceres Crop Solutions Corp. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Bioceres Crop Solutions Corp. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Corteva, Bioceres Sign Agreement to Launch Biological Insecticide in Europe MT
Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe CI
Transcript : Bioceres Crop Solutions Corp., Q3 2023 Earnings Call, May 11, 2023
Bioceres Crop Solutions Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2023 CI
More news
1 day-0.25%
1 week-0.58%
Current month-4.82%
1 month-3.52%
3 months-11.72%
6 months+10.05%
Current year-12.24%
More quotes
1 week
11.70
Extreme 11.7
12.20
1 month
11.70
Extreme 11.7
12.91
Current year
11.70
Extreme 11.7
14.05
1 year
9.76
Extreme 9.76
14.20
3 years
9.27
Extreme 9.27
16.43
5 years
0.00
Extreme 0
17.94
10 years
0.00
Extreme 0
17.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 28/02/19
Director of Finance/CFO 42 30/11/17
Chief Operating Officer 55 30/09/16
Members of the board TitleAgeSince
Director/Board Member 42 11/07/22
Director/Board Member 39 -
Director/Board Member 53 28/02/14
More insiders
Date Price Change Volume
26/04/24 12.05 -0.25% 50,913
25/04/24 12.08 +1.34% 38,331
24/04/24 11.92 -0.17% 20,035
23/04/24 11.94 -0.25% 33,061
22/04/24 11.97 -1.24% 44,000

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.05 USD
Average target price
20.25 USD
Spread / Average Target
+68.05%
Consensus